Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME

Journal of Hypertension

Volumn 17, Issue 2, 1999, Pages 221-227

  Maeso, Rosaura ^a   Navarro Cid, Josefa ^a   Rodrigo, Elena ^a   Ruilope, Luis M ^b   Cachofeiro, Victoria ^a   Lahera, Vicente ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium channel blockers; Endothelium dependent relaxation; Endothelium derived hyperpolarizing factor; Hypertension; Nitric oxide; Prostaglandins

Indexed keywords

ACETYLCHOLINE; ARGININE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHLORIDE; PROSTAGLANDIN; QUINAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RESPONSE; CELL MEMBRANE POTENTIAL; DOSE RESPONSE; MALE; MESENTERY BLOOD FLOW; NONHUMAN; ORAL DRUG ADMINISTRATION; PLETHYSMOGRAPH; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SMOOTH MUSCLE RELAXATION; SYSTOLIC BLOOD PRESSURE;

EID: 0033006108     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917020-00006     Document Type: Article

References (25)

1. G-nitro- L-arginine methyl ester on renal function and blood pressure. Am J Physiol 1991; 261:F1033-F1037.
2. Oliveira M, Antunes E, Nucci G de, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992; 20:298-303.
3. Navarro J, Sánchez A, Sáiz J, Ruilope LM, Garcia-Estañ J, Romero JC, et al. Hormonal, renal and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol 1994; 267:R1516-R1521.
4. Garcia-Estañ J, Navarro J, Atucha NM, Quesada T, Romera JC, Cachofeiro V, et al. Chronic effect of nitric oxide and prostaglandin inhibition on pressure diuresis and natriuresis in rats. Kidney Int 1996; 49 (Suppl 55):S141-S143.
5. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 1993; 21:660-666.
6. G-nitro-L-arginine as affected by blockade of pressor mechanism by the sympathetic nervous system, angiotensin, prostanoids and vasopressin. J Pharmacol Exp Ther 1992; 261:240-245.
7. G-nitro-L-arginine methyl ester. Hypertension 1996; 28:361-366.
8. Küng CF, Moreau P, Takase H, Lüscher TF. L-NAME hypertension alters endothelial and smooth muscle fucntion in rat aorta: prevention by trandolapril and verapamil. Hypertension 1995; 26:744-751.
9. Navarro-Cid J, Maeso R, Rodrigo E, Muñoz-Garcia R, Ruilope LM, Lahera V, et al. Renal and vascular consequences of the chronic nitric oxide synthase inhibition: effects of antihypertensive drugs. Am J Hypertens 1996; 9:1077-1083.
10. +]: a functional approach to separating EDHF- and EDNO-related mechanism in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol 1993; 21:423-429.
11. G-nitro-L-arginine methyl ester in rats. Am J Physiol 1992; 263:H1090-H1094.
12. Nagao T, Vanhoutte PM. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Resp Cell Mol Biol 1993; 8:1-6.
13. McCulloch AI, Bottrill FE, Randall MD, Hiley CR. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol 1997; 129:1431-1438.
14. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 1995; 92:3337-3349.
15. Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol 1992; 105:429-435.
16. Standen NB, Quayle JM, Davis J, Brayden JE, Huang Y, Nelson MT. Hyperpolarizing vasodilators activate ATP-sensitive K channels in arterial smooth muscle. Science 1989; 245:177-180.
17. Waldron GJ, Garland CJ. Effect of potassium channel blockers on L-NAME insensitive relaxations in rat small mesenteric artery. Can J Physiol Pharmacol 1994; 72 (Suppl 1):115-119.
18. Tojo A, Kobayashi N, Kimura K, Hirata Y, Matsuoka H, Yagi S, et al. Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney. Kidney Int 1996; 49 (Suppl 55):S138-S140.
19. Radomski MW, Palmer RMJ, Moncada S. The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92:646-649.
20. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995; 47:25-49.
21. Cachofeiro V, Sakakibara T, Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension 1992; 19:138-145.
22. Cachofeiro V, Maeso R, Rodrigo E, Navarro J, Ruilope LM, Lahera V. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 1995; 26:236-243.
23. Henry PD. Antiperoxidative actions of calcium antagonists and atherogenesis. J Cardiovasc Pharmacol 1991; 18 (Suppl 1):6-10.
24. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320:454-456.
25. Heim KF, Thomas G, Ramwell PW. Effect of substituted arginine compounds on superoxide production in the rabbit aorta. J Pharmacol Exp Ther 1991; 257:1130-1135.